Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Flourishing for Peace

15. november 2026 oppdatert av: Universidad del Sinú - Elías Bechara Zainúm

Flourishing for Peace Curriculum (Currículo de Florecimiento Para la Paz)

This study is a six-arm individually randomized group-treated (IRGT) trial comparing five16-week standalone flourishing curricula conditions with a control condition consisting of the regular curriculum. Participants will be individually randomized to one of the six conditions. Self-report variables and heart rate variability (HRV) data will be assessed at four time points: T1 (baseline, before the curriculum begins), T2 (8-week midterm), T3 (16-week, at the end of the curriculum), and T4 (beginning of next term), with the main outcome testing changes between T1 and T3. Primary outcomes include the lnRMSSD as a measure of HRV and the overall self-reported flourishing score. Secondary outcomes include 20 domain specific psychological scales and two other HRV measures (SDNN, and mean heart rate). Course-specific knowledge tests will also be administered to gauge participant engagement and course effectiveness. Study results will be reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) guidelines for non-pharmacological interventions.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

1050

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • (a) enrollment as a university student at UniSinu; (b) intention to remain in the campus area for at least 12 months and express a commitment to try to remain engaged in the study from beginning to end; and (c) ability to read, speak, and understand Spanish.

Exclusion Criteria:

  • No

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Grunnvitenskap
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Trippel

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Resilience and Self-Control

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Resilience and Self-Control

Eksperimentell: Stress, Coping, and Forgiveness

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Stress, Coping, and Forgiveness

Eksperimentell: Mindfulness and Meaning and Purpose

This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Mindfulness will be taught in 8 of the 16 weeks and Meaning and Purpose will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Mindfulness and Meaning and Purpose

Eksperimentell: Quality of Relationships for Peace and Positive Emotions

This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Quality of Relationships for Peace will be taught in 8 of the 16 weeks and Positive Emotions will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Quality of Relationships for Peace and Positive Emotions

Eksperimentell: Emotional Intelligence, Forgiveness, and Spirituality

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Emotional Intelligence, Forgiveness, and Spirituality

Aktiv komparator: Regular course

Participants assigned to the control condition will continue with their regular university coursework but complete the same measures as the intervention conditions.

Regular course

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Overall Flourishing: Flourish Measure
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Use the total score across 10 items of the Flourish measure developed by Tyler VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
lnRMSSD
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Heart rate variability (HRV) will be collected using a validated chest-strap sensor ( the Polar H10; Polar Electro, Kempele, Finland) during standardized resting assessments. The natural logarithm of the root mean square of successive differences between normal RR intervals (lnRMSSD), a time-domain measure of short-term heart rate variability and vagal/parasympathetic regulation, will be used as the primary HRV outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Happiness and Life Satisfaction: subscale of Flourish Measure
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Mental and Physical Health: subscale of Flourish Measure
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Meaning and Purpose: subscale of Flourish Measure
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Character and Virtue: subscale of Flourish Measure
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Close Social Relationships: subscale of Flourish Measure
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Depression symptoms: Patient Health Questionnaire-9 (PHQ-9)
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 3. Higher score indicates more severe depressive symptoms.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Anxiety Symptoms: Generalized Anxiety Disorder-7 (GAD-7)
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 3. Higher scores more severe anxiety symptoms.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
The Short Stress Overload Scale
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher stress.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Coherence: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Purpose: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Significance: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Trait Forgivingness Scale
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher forgiveness.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Trait Humility: subscale of Relational Humility Scale
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher humility.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 4. Higher score indicates higher mindfulness.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Brief Self-Control Scale
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher self-control

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Brief Resilience Scale
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher resilience.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Loneliness: NIH Toolbox Adult Social Relationship Scales
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of loneliness

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Transcendent Spirituality: subscale of Trait Sources of Spirituality Scale
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of spirituality

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Persevering Hope Scale
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of hope

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Coping Self-Efficacy Scale
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 10. Higher score indicates higher level of self-efficacy

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
SDNN
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Standard Deviation of Normal-to-Normal intervals, another HRV measure

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Mean Heart Rate
Tidsramme: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Mean Heart Rate

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. januar 2027

Primær fullføring (Antatt)

1. august 2027

Studiet fullført (Antatt)

1. desember 2027

Datoer for studieregistrering

Først innsendt

15. november 2026

Først innsendt som oppfylte QC-kriteriene

15. november 2026

Først lagt ut (Faktiske)

20. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

20. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

15. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • Acta No. 005 de 2025

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .